Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Vidofludimus Calcium for Primary Sclerosing Cholangitis
- First Posted Date
- 2018-10-29
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Elizabeth Carey
- Target Recruit Count
- 18
- Registration Number
- NCT03722576
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Phoenix, Arizona, United States
🇺🇸Arizona State University, Tempe, Arizona, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
Vancomycin for Primary Sclerosing Cholangitis
Phase 2
Active, not recruiting
- Conditions
- Primary Sclerosing Cholangitis
- Interventions
- Other: Placebo
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Elizabeth Carey
- Target Recruit Count
- 102
- Registration Number
- NCT03710122
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸Arizona State University, Tempe, Arizona, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
News
No news found